Zhiqiang Qin

High Impact

Associate Professor

University of Arkansas for Medical Sciences

faculty

Pathology, College of Medicine

24 h-index 87 pubs 1,805 cited

Research Areas

Cancer-related molecular mechanisms research Tissue Engineering and Regenerative Medicine Immune Response and Inflammation Mesenchymal stem cell research Ubiquitin and proteasome pathways Prostate Cancer Treatment and Research Microbial infections and disease research Metabolism and Genetic Disorders

Links

ORCID Research Group UAMS TRI Profile

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Zhiqiang Qin's research group investigates mechanisms underlying disease progression and potential therapeutic targets, with a focus on cancer and tissue repair. His work has explored the role of the NLRP3 inflammasome in prostate cancer malignancy and the activation of caspase-1. Additionally, his group has examined the involvement of USP15 in testicular oxidative stress injury via the Keap1/Nrf2 pathway and the contribution of P4HA1 to proliferation and colony formation in lung cancer by activating the E2F transcription factor 1.

Further research extends to regenerative medicine and infection management. This includes the construction of tissue-engineered bladders utilizing an artificial acellular nanocomposite scaffold loaded with stromal vascular fraction secretome. Investigations have also assessed the effect of uncultured adipose-derived stromal vascular fraction in preventing urethral stricture formation in rats. His group has also published on metal-based antimicrobial agents for wound dressings, addressing infection management and antibiotic resistance.

Qin holds an h-index of 24 with over 1,805 citations across 87 publications, and is recognized as a highly cited researcher. He collaborates with Steven R. Post at the University of Arkansas for Medical Sciences.

Metrics

h-index: 24
Publications: 87
Citations: 1,805

Selected Publications

Abstract 2987: Role of EIF4G1 network in non-small cell lung cancers (NSCLC) pathogenesis and development of targeted therapy (2025) DOI

Grants & Funding

Seeds of Science Pilot award UAMS Internal Research Awards Principal Investigator
Development of O'PROTACs-based Novel EIF4G1 Degraders for Treatment of Non-small Cell Lung Cancer US Department of Defense Principal Investigator
Defining mechanisms of KSHV pathogenesis using MHV68-KSHV chimeric viruses NIH Co-Investigator
Seeds of Science Pilot award UAMS Internal Research Awards Principal Investigator
Periodontal bacteria enhance oral KSHV pathogenesis and Kaposi's Sarcoma development in HIV + patients - Continuation NIH/Nat. Cancer Institute Principal Investigator